Ledger.Open graph →
SEC Form D · filed June 27, 2019

RELMADA THERAPEUTICS, INC

Offering
$10.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Ottavio Vitolo · New York, NYExecCharles Casamento · New York, NYDirectorSergio Traversa · New York, NYExec · DirectorPaul Kelly · New York, NYDirectorMaged Shenouda · New York, NYDirectorCorey B. Mulloy · Seattle, WADirectorKevin Mcallister · BALTIMORE, MDDirectorHoward Davner · Freehold, NJExec · DirectorRocco Lavista · Freehold, NJExecDanny Lin · SAN MATEO, CADirectorChristopher Bentley · Spring, TXDirectorMason H. Resch · Chicago, ILDirectorTyler J. Resch · Chicago, ILDirectorJonpaul J. Jonkheer · Chicago, ILExec · DirectorDominic A. Bassani · Old Bethpage, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗